Tag: MHRA
-
MHRA issues new guidance for people using mental health apps
New MHRA guidance helps the public navigate mental health apps The Medicines and Healthcare products Regulatory Agency (MHRA) has published new guidance aimed at helping people choose and use mental health apps and other digital tools more safely. Released in collaboration with NHS England, the guidance is part of free online resources designed to improve…
-
MHRA Publishes New Guidance to Help People Choose Mental Health Apps and Digital Tools
New guidance from MHRA aims to help people navigate mental health apps and digital tools In a move designed to empower patients and caregivers, the Medicines and Healthcare products Regulatory Agency (MHRA) has published fresh guidance for individuals using mental health apps and related digital tools. Released on 27 January as part of a broader…
-
MHRA Publishes New Guidance for Using Mental Health Apps
New MHRA guidance aims to steer safer use of mental health apps The Medicines and Healthcare products Regulatory Agency (MHRA) has today published fresh guidance designed to help the public navigate mental health apps and other digital health tools. Created in partnership with NHS England as part of a series of free online resources, the…
-
Fake weight-loss medication in tablet form could flood Britain, experts warn
Overview: A new threat to public health Health experts are sounding the alarm about fake weight-loss medications that could reach Britain in tablet form. At present, most approved weight-loss drugs in the UK are administered by injection. The emergence of counterfeit tablets could broaden access to unverified products, raising concerns about safety, effectiveness, and consumer…
-
UK Crime Gangs Turn to Branded Weight-Loss Drugs, Blurring Lines With Legitimate Medicine
Growing Threat: Criminals Are Manufacturing Branded Weight-Loss Drugs UK authorities have raised alarms that organised crime gangs are now producing their own branded weight-loss drugs. The trend, described by the Medicines and Healthcare products Regulatory Agency (MHRA) as a significant threat, involves illicit labs creating pills and liquids that look like legitimate medicines and are…
-
UK crime gangs shift to branded weight-loss drugs, posing public health risk
In a disturbing development for public health, UK authorities say organised crime gangs are moving into the manufacture of branded weight-loss drugs that closely resemble legitimate medicines. The move, described by the Medicines and Healthcare products Regulatory Agency (MHRA) as a growing threat, combines counterfeit chemistry with sophisticated branding to lure unsuspecting consumers. Officials warn…
-
UK Crime Gangs Move Into Branded Weight-Loss Drugs, Raising Public Health Alarm
Overview: A growing threat to public health Authorities in the United Kingdom have issued a stark warning: organised crime groups are increasingly manufacturing their own branded weight-loss drugs and distributing them as if they were legitimate medicines. The emergence of this homegrown illicit supply chain raises serious concerns about safety, efficacy and the broader risks…
-
MedSafetyWeek 2024: MHRA Urges Public to Report Side Effects and Suspected Fake Medicines
What is MedSafetyWeek and why it matters MedSafetyWeek is an international initiative now in its tenth year, uniting more than 130 medicines regulators and health organisations across 117 countries. The campaign emphasizes the importance of public participation in pharmacovigilance: reporting suspected side effects from medicines and incidents involving medical devices. When people share experiences with…
-
MHRA Urges Public to Report Medicine Side Effects and Suspect Counterfeits During MedSafetyWeek
Overview: MedSafetyWeek Spotlight on Medicines Safety As the tenth annual MedSafetyWeek kicks off, regulatory bodies and health organisations from more than 130 regulators across 117 countries unite to emphasise a simple, powerful idea: report safety concerns about medicines and medical devices. The Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom is joining…
-
MedSafetyWeek 2025: MHRA Urges Public to Report Side Effects and Suspected Fakes
Why MedSafetyWeek Matters The tenth annual MedSafetyWeek mobilizes regulators, health organisations, and the public in a joint effort to safeguard medicine use worldwide. Coordinated by more than 130 medicines regulators and health bodies across 117 countries, the campaign emphasizes the critical role citizens play in pharmacovigilance. By reporting unexpected side effects and concerns about medicines…